★ Gazelle Enterprises (Top 10 High-tech Enterprises )

★ 3551 Optics Valley Talent Programme

★Innovative small and medium-sized enterprises

★Inhaled COVID-19 vaccine: received clinical approval in Singapore

★PCV13 vaccine: initiated PhI Clinical Trail

★To lead the National Key R&D Plan--Research on Etiology and Epidemic Prevention Technology System

★Future Star TOP100 of Wuhan in 2021

★ “Gazelle Enterprise”2021

★ Inhaled COVID-19 vaccine: received clinical approval in Brazil

★ National Rising Star of 2020

★"Gazelle Enterprise" 2020

★Top 10 Venture Capital Favorite Gazelle Enterprises

★Council member of China Association of Vaccines (CAV)

★Award for High-Growth of TOP20 and Rising Star of 2020

★Engineering Laboratory in Hubei Province

★ “ Innovative Talent” of the 12th “3551 Optics Valley Talent programme” 

★The 2nd “ State Level High-tech Enterprise of 2019”

★High-tech Enterprise

★ "Gazelle Enterprise" 2019

★National Technology Enterprise

★Awarded subsidies from the 2nd  " 1k Enterprises and 10k Talents Plan"

★Hubei Enterprise Technology Center

★The 11th  “3551 Optics Valley Talent Programme”

★ "Gazelle Enterprise" 2018

★National Innovation Business Good Faith Demonstration unit 

★Equity Financing Contribution Award of Wuhan Biolake in 2017

★National Technology Enterprise

★China AAA Grade Credit Enterprise

★ "Gazelle Enterprise" 2017

★The 1st  " 1k Enterprises and 10k Talents Plan" of Wuhan

★The team of provincial “ entrepreneurship and innovation strategy” in 2016

★ High-tech Enterprise

★Gazelle Enterprises of 2016

★The team of “ Entrepreneurship and Innovation Strategy” in 2015 by Hubei Provincial Government

★Provincial-advanced unit of Bio-safety Laboratory Management in the system

★The 9th “ 3551 Optics Valley Talent Programme”

★ Member of DCVMN

★The title “ Enterprise Innovation Talent” of the 8th  “ 3551 Optics Valley Talent Programme” 

★Council member of Hubei Provincial Biochemical Innovation Network

★Provincial-level Bio-safety Laboratory

★Hubei Provincial Key Laboratory for New Vaccine and Recombinant Protein